Shannon Barker
About
In The Last Decade
Shannon Barker
18 papers receiving 834 citations
Peers
Comparison fields: 5 of 75
- Genetics 597
- Molecular Biology 554
- Oncology 431
- Biotechnology 154
- Immunology 76
Countries citing papers authored by Shannon Barker
This map shows the geographic impact of Shannon Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Barker more than expected).
Fields of papers citing papers by Shannon Barker
This network shows the impact of papers produced by Shannon Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Barker. The network helps show where Shannon Barker may publish in the future.
Co-authorship network of co-authors of Shannon Barker
This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Barker. A scholar is included among the top collaborators of Shannon Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Barker. Shannon Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 14 | |
| 4 | 9 | |
| 5 | 33 | |
| 6 | 27 | |
| 7 | Defining a Research Domain in an Emerging Technology: Vaccine Research in the State of Georgia | 2 |
| 8 | 33 | |
| 9 | 86 | |
| 10 | 40 | |
| 11 | 23 | |
| 12 | CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses. | 34 |
| 13 | 23 | |
| 14 | 54 | |
| 15 | Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. | 208 |
| 16 | 97 | |
| 17 | 34 | |
| 18 | Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications. | 40 |
| 19 | 35 | |
| 20 | 57 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.